Kristine M Ball insider trades

Open-market stock purchases and sales by Kristine M Ball, Director at Oruka Therapeutics, Inc, from SEC Form 4 filings since Aug 14, 2014.

Recent trades

DateStockTradeValue
Jun 2, 2026ORKA Oruka Therapeutics, IncBought (not open market)—

Companies traded

  • ORKA Oruka Therapeutics, Inc: other filings, last Jun 2, 2026
  • BCEL Atreca, Inc: other filings, last Jun 13, 2023
  • FTSV Forty Seven, Inc: other filings, last Apr 7, 2020
  • MNLO Menlo Therapeutics Inc: other filings, last Dec 11, 2019
  • RLYP Relypsa Inc: 1 buy, 5 sales, last Sep 1, 2016

Get free alerts when Kristine M Ball files a new trade →